These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12939400)

  • 1. Potential role of MLH1 in the induction of p53 and apoptosis by blocking transcription on damaged DNA templates.
    Yanamadala S; Ljungman M
    Mol Cancer Res; 2003 Aug; 1(10):747-54. PubMed ID: 12939400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress.
    Hardman RA; Afshari CA; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1392-7. PubMed ID: 11245440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1.
    McKay BC; Chen F; Clarke ST; Wiggin HE; Harley LM; Ljungman M
    Mutat Res; 2001 Mar; 485(2):93-105. PubMed ID: 11182541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
    Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
    Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
    Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLH1 function is context dependent in colorectal cancers.
    Jackson T; Ahmed MA; Seth R; Jackson D; Ilyas M
    J Clin Pathol; 2011 Feb; 64(2):141-5. PubMed ID: 21169277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.
    Fedier A; Poyet C; Perucchini D; Boulikas T; Fink D
    Anticancer Drugs; 2006 Mar; 17(3):315-23. PubMed ID: 16520660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
    Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
    Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.
    Tentori L; Leonetti C; Muzi A; Dorio AS; Porru M; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Int J Oncol; 2013 Jul; 43(1):210-8. PubMed ID: 23653048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
    Fedier A; Erdmann R; Boulikas T; Fink D
    Int J Oncol; 2006 Nov; 29(5):1303-10. PubMed ID: 17016665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells.
    Zeng X; Kinsella TJ
    Autophagy; 2007; 3(4):368-70. PubMed ID: 17426439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.
    Peterson-Roth E; Reynolds M; Quievryn G; Zhitkovich A
    Mol Cell Biol; 2005 May; 25(9):3596-607. PubMed ID: 15831465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair and p53 independently affect sensitivity to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea.
    Aquilina G; Ceccotti S; Martinelli S; Soddu S; Crescenzi M; Branch P; Karran P; Bignami M
    Clin Cancer Res; 2000 Feb; 6(2):671-80. PubMed ID: 10690553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling cell cycle arrest and cell death through the MMR System.
    O'Brien V; Brown R
    Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
    Stubbert LJ; Smith JM; McKay BC
    BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
    Chen J; Sadowski I
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.